The prevalence of human papillomavirus in oropharyngeal cancer is increasing regardless of sex or race, and the influence of sex and race on survival is modified by human papillomavirus tumor status

Farhoud Faraji, Eleni M. Rettig, Hua‐Ling Tsai, +4

Cancer

Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide

Amy E. DeZern, Clio Franklin, Hua‐Ling Tsai, +3

Blood Advances

Chronic GvhdTransplantationMarrow TransplantationHaploidentical TransplantationPosttransplant Cyclophosphamide +12

Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning

Shannon R. McCurdy, Vedran Radojčić, Hua‐Ling Tsai, +13

Blood

Racial disparities in the rate of cardiotoxicity of HER2‐targeted therapies among women with early breast cancer

Anya M. Litvak, Bhavina Batukbhai, Stuart D. Russell, +10

Cancer

Methylation Biomarker Panel Performance in EsophaCap Cytology Samples for Diagnosing Barrett's Esophagus: A Prospective Validation Study

Zhixiong Wang, Swetha Kambhampati, Yulan Cheng, +17

Clinical Cancer Research

Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial

Phuoc T. Tran, Kathryn Lowe, Hua‐Ling Tsai, +27

Journal of Clinical Oncology

HLA-matching with PTCy: a reanalysis of a CIBMTR dataset with propensity score matching and donor age

Alexander J. Ambinder, Tania Jain, Hua‐Ling Tsai, +3

Blood Advances

Tumor size and presence of calcifications on ultrasonography are pre‐operative predictors of lymph node metastases in patients with papillary thyroid cancer

Nephtali R. Gómez, Guennadi Kouniavsky, Hua‐Ling Tsai, +7

Journal of Surgical Oncology

Post-Transplantation Cyclophosphamide-Based Graft- versus-Host Disease Prophylaxis with Nonmyeloablative Conditioning for Blood or Marrow Transplantation for Myelofibrosis

Tania Jain, Hua‐Ling Tsai, Amy E. DeZern, +24

Transplantation and Cellular Therapy

Prospective PTCTC trial of myeloablative haplo-BMT with posttransplant cyclophosphamide for pediatric acute leukemias

Juan C. Fierro Pineda, Hua‐Ling Tsai, Amanda L. Blackford, +17

Blood Advances

Pediatric Acute LeukemiasMixed-phenotype Acute LeukemiaImmunologyProspective Ptctc TrialPharmacotherapy +17